Detalhe da pesquisa
1.
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
Blood
; 143(14): 1391-1398, 2024 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38153913
2.
Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation.
Blood
; 131(13): 1464-1475, 2018 03 29.
Artigo
Inglês
| MEDLINE | ID: mdl-29348129
3.
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
Acta Haematol
; 143(3): 217-231, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-31590170
4.
Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy.
Blood
; 130(18): 2027-2031, 2017 11 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28827408
5.
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.
Blood
; 128(6): 774-82, 2016 08 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27121472
6.
Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.
Int J Cancer
; 139(8): 1799-809, 2016 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27253354
7.
Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute lymphoblastic leukemia.
Biol Blood Marrow Transplant
; 20(10): 1522-9, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24907626
8.
A multicentre, randomized trial in adults with de novo Philadelphia-Chromosome positive acute lymphoblastic leukemia to assess the efficacy of ponatinib versus imatinib in combination with low-intensity chemotherapy, to compare end of therapy with indication for SCT versus TKI, blinatumomab and chemotherapy in optimal responders and to evaluate blinatumomab in suboptimal responders (GMALL-EVOLVE).
Oncol Res Treat
; 2024 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38754400
9.
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL.
J Clin Oncol
; 42(3): 273-282, 2024 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37883727
10.
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines.
Leukemia
; 2024 May 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38744919
11.
A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia.
BMC Pharmacol Toxicol
; 21(1): 70, 2020 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-32993794
12.
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia.
Bone Marrow Transplant
; 55(7): 1410-1420, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32001801
13.
Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia.
Leukemia
; 34(8): 2087-2101, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32439895
14.
First-line treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in adults.
Curr Opin Oncol
; 21 Suppl 1: S43-6, 2009 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-19561414
15.
Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous Transplantation.
Cell Rep
; 27(7): 2022-2028.e3, 2019 05 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31091442
16.
An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR.
Haematologica
; 92(7): 970-3, 2007 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-17606448
17.
Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells.
Cancer Res
; 65(7): 2537-41, 2005 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15805245
18.
Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options.
Am J Case Rep
; 18: 1099-1109, 2017 Oct 16.
Artigo
Inglês
| MEDLINE | ID: mdl-29033451
19.
Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia.
Cancer Cell
; 30(6): 849-862, 2016 Dec 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27916615
20.
Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations.
Eur J Haematol
; 85(5): 457-9, 2010 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-20659156